BMJ Open (Apr 2024)

REporting quality of PilOt randomised controlled trials in surgery (REPORTS): a methodological survey protocol

  • Lehana Thabane,
  • Mohit Bhandari,
  • Sameer Parpia,
  • Keean Nanji,
  • Sophia Zhang,
  • Alex Thabane,
  • Tyler McKechnie,
  • Tania Kazi,
  • Austine Wang,
  • Aristithes G Doumouras,
  • Cagla Eskicioglu

DOI
https://doi.org/10.1136/bmjopen-2024-085293
Journal volume & issue
Vol. 14, no. 4

Abstract

Read online

Introduction The aim of this methodological review is to evaluate the completeness of reporting of surgical pilot and feasibility randomised trials as per the Consolidated Standards of Reporting Trials (CONSORT) extension to randomised pilot and feasibility trials. Moreover, we aim to assess for the presence of spin reporting and inconsistency between abstract and main text reporting in surgical pilot and feasibility randomised trials.Methods and analysis A comprehensive, electronic search strategy will be used to identify studies indexed in Medline, Embase and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Studies will be included if they are pilot or feasibility randomised trials of surgical interventions. The primary outcome will be overall CONSORT statement extension to randomised pilot and feasibility trials checklist completeness. This will be defined as trials reporting each of the 40 items in the CONSORT statement extension to randomised pilot and feasibility trials checklist. Secondary outcomes will include the reporting of individual studies as per the CONSORT extension to randomised pilot and feasibility trials, the use of spin reporting strategies, trial factors associated with reporting quality and spin strategy use, and consistency between abstract and main text reporting. Poisson and logistic regressions will be performed to explore the association between trial factors and completeness of reporting as measured by the number of reported CONSORT items.Ethics and dissemination This is a methodological survey that has been registered a priori on the International Prospective Register for Systematic Reviews (PROSPERO) (CRD42023475512). Local ethics approval is not required. We plan to disseminate study results through peer-reviewed publication and conference presentations.